Article
Prevalence of the factor V leiden mutation in children and neonates with thromboembolic disease.
The Journal of pediatrics - 1 Dec 1998
Hagstrom J N, Walter J, Bluebond-Langner R, Amatniek J C, Manno C S, High K A
Abstract excerpt
OBJECTIVE: Resistance to activated protein C (APC) has been identified as a risk factor for thrombotic disease in adults. In over 90% of cases, the basis for the APC resistance is a mutation in the coagulation factor V gene (factor V Leiden) that renders the protein more resistant to inactivation by APC. We sought to determine the prevalence of the factor V Leiden (FVL) mutation in neonates and children who had...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
